TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
5.46
-0.08 (-1.44%)
Dec 3, 2024, 1:44 PM EST - Market open
TuHURA Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 3.35 | 4.14 | 2.01 |
| Research & Development | 11.27 | 9.4 | 7.93 |
| Operating Expenses | 14.61 | 13.55 | 9.93 |
| Operating Income | -14.61 | -13.55 | -9.93 |
| Interest Expense | -3.63 | -0.02 | - |
| Interest & Investment Income | 0.21 | 0.09 | 0.06 |
| Other Non Operating Income (Expenses) | -0.31 | 0.04 | 0.21 |
| EBT Excluding Unusual Items | -18.35 | -13.43 | -9.66 |
| Other Unusual Items | - | 0.33 | 0.29 |
| Pretax Income | -18.37 | -29.32 | -9.37 |
| Net Income | -18.37 | -29.32 | -9.37 |
| Net Income to Common | -19.33 | -29.32 | -9.37 |
| Shares Outstanding (Basic) | 76 | 68 | - |
| Shares Outstanding (Diluted) | 76 | 68 | - |
| EPS (Basic) | -0.25 | -0.43 | - |
| EPS (Diluted) | -0.25 | -0.43 | - |
| Free Cash Flow | -15.24 | -13.25 | -7.54 |
| Free Cash Flow Per Share | -0.20 | -0.19 | - |
| EBITDA | -14.48 | -13.37 | -9.56 |
| D&A For EBITDA | 0.14 | 0.18 | 0.37 |
| EBIT | -14.61 | -13.55 | -9.93 |
Source: S&P Capital IQ. Standard template.
Financial Sources.